BrainsWay Ltd. reiterated earnings guidance for the year 2023. As a reminder, the company continue to expect to demonstrate revenue growth over 2022 and are targeting breakeven operating income.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
1,037 ILa | -2.81% | -4.60% | -9.75% |
05-09 | Oppenheimer Adjusts Brainsway Price Target to $11 From $10, Maintains Outperform Rating | MT |
05-09 | HC Wainwright Adjusts Price Target on Brainsway to $15 From $13, Keeps Buy Rating | MT |
Quarterly revenue - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-9.75% | 92.58M | |
+11.08% | 226B | |
+9.30% | 188B | |
+13.00% | 137B | |
+25.98% | 108B | |
+0.34% | 63.19B | |
+12.41% | 52.26B | |
+5.62% | 51B | |
+6.71% | 43.89B | |
+5.78% | 38.07B |
- Stock Market
- Equities
- BWAY Stock
- News BrainsWay Ltd.
- BrainsWay Ltd. Reiterates Earnings Guidance for the Year 2023